To evaluate the role of tumor-derived IL-8 on survival, expression levels of IL-8 and its receptors CXCR1 and CXCR2 were quantified by RNA microarrays from pre- and post-treatment tumor samples from oncolytic virus treated patients. This evidence concerns the gene CXCL8 and neoplasm.